Kick-off meeting of the TOWWERS showcase project: 1

COVID-19 Market adoption modernization care gaps improvement chronic disorders convener healthcare system transformation populational RWD/RWE strategic committee structured collaboration value-based healthcare

Journal

Expert review of pharmacoeconomics & outcomes research
ISSN: 1744-8379
Titre abrégé: Expert Rev Pharmacoecon Outcomes Res
Pays: England
ID NLM: 101132257

Informations de publication

Date de publication:
Jul 2022
Historique:
pubmed: 22 3 2022
medline: 6 7 2022
entrez: 21 3 2022
Statut: ppublish

Résumé

The COVID-19 pandemic has highlighted the need to modernize healthcare systems to the reality of the 21st century. The first world-wide Strategic Committee to launch Collaborative Value-Based Healthcare (C-VBHC) anchored on populational Real World Data and structured collaboration, took place in Montreal, via TOWWERS showcase project. The meeting covered a broad range of topics from the perspective of each of the various Real-World healthcare actors, the 5P+: Patient, Prescriber, Producer, Policymaker, Payer, including Data and Research stakeholders. Attended by approximately 20 participants from North America and Europe, the meeting provided a valuable opportunity to unit the 5P+ around common goals and exchanging on solutions. TOWWERS Strategic committee identified key elements required to continue the transformation.

Identifiants

pubmed: 35312399
doi: 10.1080/14737167.2022.2055549
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

711-715

Auteurs

Julie Frappier (J)

Data 4 Actions, Montreal, Quebec, Canada.

Marilyn Krelenbaum (M)

Marilyn Krelenbaum Consultancy Group, Hampstead, Quebec, Canada.

Eva Villalba (E)

Quebec Cancer Coalition, Saint-Lambert, Quebec, Canada.

Pierre Martin (P)

GMF du Cap, Trois-Rivières, Quebec, Canada.

Nadia Nour (N)

Bristol Myers Squibb Canada Co. - Regional Clinical Operations, Saint-Laurent, Quebec, Canada.

Jacques L'Espérance (J)

J. L'esperance Actuariat Conseil, Montreal, Quebec, Canada.

Anie Perrault (A)

BioQuebec, Bromont, Quebec, Canada.

Barbara Decelle (B)

IVADO, Montreal, Quebec, Canada.

Anne-Marie Larose (AM)

Point Cardinal, Montreal, Quebec, Canada.

Valérie Viau (V)

W- Synchronicity Inc, Montreal, Quebec, Canada.

Richard Fahey (R)

AppEco, Montreal, Quebec, Canada.

Jean-François Denault (JF)

Impacts, Montreal, Quebec, Canada.

Isabelle Fauchon (I)

Hackordage, Communicangel, HEC Paris, Paris, France.

Maxime Huard (M)

Data 4 Actions, Montreal, Quebec, Canada.

Manon Frappier (M)

Data 4 Actions, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH